Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328 (14 February), doi:10.1136/bmj.328.7436.0-f
A useful tip for smart arse medical students. If asked: "What is the treatment for x?" Don't answer: "y." Instead answer: "Whatever the patient chooses together with me after being fully informed of the pluses and minuses of all options." Giving patients choice in complex circumstances emerges as a theme in this issuewith the sombre overtone that not to give patients choice is to abuse them.
It first hit me that denying patients choice is a form of abuse when about six years ago I read a paper on patient choice in screening for colorectal cancer. One hundred Californian patients were given full information on five options: nothing, faecal occult blood testing, barium enema examination, flexible sigmoidoscopy, or colonoscopy. Patients were told about the nature of the test, the preparation required, the need for sedation, the time required, how often the test would be repeated, the likely results with both positive and negative outcomes in detail, and the cost. The result was that patients chose very different options.
Steve Woolf, a family physician and North American editor of the BMJ, wrote: "Suppose these same 100 patients had not received this information and were instead cared for by a physician who routinely performs flexible sigmoidoscopy because he considers it the best test. According to these data, fully 87% of the patients would undergo a procedure other than the one they would prefer if properly informed" ( J Fam Pract 1997;45: 205-8[Web of Science][Medline]). Nine out of 10 patients have been abused.
Mark Sculpher and others describe how they used something called a discrete choice experiment to help men with non-metastatic prostate cancer to choose between different options for treatment (p 382). The main conclusions are that men are willing to engage in this complex process and will trade life expectancy in order to avoid side effects. Mandy Ryan discusses how the technique can be used in other circumstances (p 358).
Some 15-20 years ago an editorial in the BMJ suggested that every menopausal woman should have hormone replacement therapy. That now looks like bad advice not only because therapy increases the risk of breast cancer, heart disease, and thrombembolism but also because only women themselves can trade off how they value the benefits and risks. A group from Leicester present a detailed decision analysis of the harms and benefits of therapy in the light of the latest evidence and conclude that two important variables are perceived symptoms and baseline risk of breast cancer (p 371). Klim McPherson weighs up hormone replacement therapy and also draws lessons from the whole sorry story of the mass drugging of women for largely non-existent benefits (p 357).
The main arguments against fully informing patients are that "It's too difficult, costly, and time consuming." But they are neither evidence based nor politically sustainable.
Richard Smith, editor
rsmith{at}bmj.com
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses